Screening for Hepatitis B, Hepatitis C and HIV in Drug Users and Vulnerable People
Tests combined screening for hepatitis B, C and HIV in addiction care settings.
Plain-language title generated from the registry record
Registry title: Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
Key facts
- Where
- Limoges, FranceSee the site
Where in France
- Limoges university hospitalLimoges, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Limoges
- Trial code
- NCT06904820
- Record updated
- 14 August 2025
- Original description
The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively improve HCV patient's health outcomes. The main objective of the SCANVIR project was to evaluate the feasibility, acceptability and reproducibility of a "test, treat and cure" strategy for PWIDs and vulnerable populations during dedicated days in addiction care centers.Read full original descriptionShow less
Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively improve HCV patient's health outcomes. The main objective of the SCANVIR project was to evaluate the feasibility, acceptability and reproducibility of a "test, treat and cure" strategy for PWIDs and vulnerable populations during dedicated days in addiction care centers.
Inclusion: Adult 18 and over; Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector; Patient not opposed to research.
Exclusion: Age under 18; Patient opposed to research.